These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33615122)

  • 1. Use of biologics in chronic spontaneous urticaria - beyond omalizumab therapy?
    Metz M; Maurer M
    Allergol Select; 2021; 5():89-95. PubMed ID: 33615122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
    Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
    Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
    Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
    Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.
    Metz M; Vadasz Z; Kocatürk E; Giménez-Arnau AM
    Clin Rev Allergy Immunol; 2020 Aug; 59(1):38-45. PubMed ID: 32418171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.
    Giménez-Arnau AM
    Expert Opin Biol Ther; 2017 Mar; 17(3):375-385. PubMed ID: 28125304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.
    Casale TB; Gimenez-Arnau AM; Bernstein JA; Holden M; Zuberbier T; Maurer M
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2573-2588. PubMed ID: 37776480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IgE for the Treatment of Chronic Urticaria.
    Wedi B; Traidl S
    Immunotargets Ther; 2021; 10():27-45. PubMed ID: 33628747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of targeted therapy in chronic spontaneous urticaria.
    Min TK; Saini SS
    Ann Allergy Asthma Immunol; 2024 Oct; 133(4):367-373. PubMed ID: 38885835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study.
    Palladino A; Villani F; Pinter E; Visentini M; Asero R
    Eur Ann Allergy Clin Immunol; 2024 Mar; ():. PubMed ID: 38482859
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging Therapies in Chronic Spontaneous Urticaria.
    Min TK; Saini SS
    Allergy Asthma Immunol Res; 2019 Jul; 11(4):470-481. PubMed ID: 31172716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis.
    Manzoor H; Razi F; Rasheed A; Sarfraz Z; Sarfraz A; Robles-Velasco K; Felix M; Cherrez-Ojeda I
    Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36554102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expanding Field of Biologics in the Management of Chronic Urticaria.
    Joshi S; Khan DA
    J Allergy Clin Immunol Pract; 2017; 5(6):1489-1499. PubMed ID: 28734860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.
    Marzano AV; Genovese G; Casazza G; Fierro MT; Dapavo P; Crimi N; Ferrucci S; Pepe P; Liberati S; Pigatto PD; Offidani A; Martina E; Girolomoni G; Rovaris M; Foti C; Stingeni L; Cristaudo A; Canonica GW; Nettis E; Asero R
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):918-924. PubMed ID: 30451325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues.
    Wieder S; Maurer M; Lebwohl M
    Am J Clin Dermatol; 2015 Feb; 16(1):19-26. PubMed ID: 25452254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges and controversies in the management of chronic spontaneous urticaria.
    Asero R; Pinter E; Marra AM; Tedeschi A; Cugno M; Marzano AV
    Expert Rev Clin Immunol; 2015; 11(10):1073-82. PubMed ID: 26174347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urticaria and Angioedema: an Update on Classification and Pathogenesis.
    Radonjic-Hoesli S; Hofmeier KS; Micaletto S; Schmid-Grendelmeier P; Bircher A; Simon D
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):88-101. PubMed ID: 28748365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
    Ghazanfar MN; Holm JG; Thomsen SF
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.